Drawing for TME PHARMA

USPTO serial 79360076

TME PHARMA

Reviewed by CopyMark Law Group

Reg. 7423863Status 700Registered
Filing date
Status date
Registration date
Jun 25, 2024
Examiner
BULLOFF, TOBY ELLEN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TME PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ursula B. Day

Ursula B. Day law firm of Ursula B. Day35 west 35th streetSuite 900New York, NY 10001

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science, in particular compounds of nucleic acids and derivatives thereof and l-nucleotides and proteins and peptides and derivatives thereof, all for use in the production and development of pharmaceuticals, veterinary and biotechnological products;ACTIVE—
005Medicines, medical preparations and medicines for animals, namely, for treating cancer and ophthalmological indications, diagnostic agents for pharmaceutical use; pharmaceuticals and natural remedies, namely, for treating cancer and ophthalmological indications; pharmaceutical compositions, namely, for treating cancer and ophthalmological indications; pharmaceutical preparations, namely, for treating cancer and ophthalmological indications;ACTIVE—
042Science and technology services, namely, scientific analysis in the field of biotechnology, therapeutics and research and planning services relating to development of pharmaceuticals; medical and pharmacological research services; pharmaceutical research; computer software design; design of databases, design of online databases; computer programming, namely, updating, design and rental of computer software for managing medical patient data, medical teaching and interactive medical simulations; providing online, non-downloadable computer programs and data networks for managing medical patient data, medical teaching and interactive medical simulations; scientific and technological services, namely, scientific analysis in the field of biotechnology, therapeutics and research and design relating thereto in the field of genetic engineering; scientific research for medical purposes and for biochemical use, scientific contract research; research and development of processes, syntheses and devices for the medical sector and research in the fields of chemistry, biology, biophysics, medicine, biochemistry, genetics, genetic engineering, bacteriology; scientific experiments and analyses; surveying; chemistry services, namely, laboratory research in the field of chemistry, biotechnology, medicine; chemical laboratories; medical laboratory servicesACTIVE—
044Medical services in the field of medicine; medical and clinical examinations; pharmaceutical advice;ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 5, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 12, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 11, 2024FIMPFINAL DISPOSITION PROCESSED—
Sep 25, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 25, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 25, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 10, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 15, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 27, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 20, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 29, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 29, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Feb 29, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 29, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 29, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 28, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 28, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2023RFNPREFUSAL PROCESSED BY IB—
Sep 14, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 13, 2023RFRRREFUSAL PROCESSED BY MPU—
Aug 23, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 22, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2023DOCKASSIGNED TO EXAMINER—
Jan 17, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 13, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 12, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance